Literature DB >> 22357386

Visual function changes after punctal occlusion with the treatment of short BUT type of dry eye.

Minako Kaido1, Reiko Ishida, Murat Dogru, Kazuo Tsubota.   

Abstract

PURPOSE: To evaluate visual function changes after punctal plug (PP) occlusion in patients with short breakup time of tear film (BUT) type of dry eyes.
METHODS: A prospective comparative study was performed in 43 eyes of 43 dry eye patients with short BUTbreakup time of tear film receiving PP occlusion. Patients were divided into 2 groups as those receiving only upper or only lower occlusion. Functional visual acuity measurements, tear function evaluations, and questionnaire on satisfaction with treatment in relation to presence of epiphora were performed before and 1 month after PP insertion.
RESULTS: Twenty eyes of 43 eyes (46.5%) with only lower occlusion and 17 eyes of 43 eyes (39.5%) with only upper occlusion showed satisfactory outcomes with treatment. One of 43 eyes (2.3 %) had epiphora. Vital staining scores and BUT values significantly improved in both groups after occlusion. The mean logarithm of the minimum angle of resolution functional visual acuity value significantly improved only in eyes receiving upper PP occlusion.
CONCLUSION: Upper PP occlusion seems to be associated not only with improvement of tear stability, vital staining scores, and treatment-related satisfaction but also with better quality of visual function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22357386     DOI: 10.1097/ICO.0b013e31823f8cfc

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  9 in total

Review 1.  Punctal occlusion for dry eye syndrome.

Authors:  Ann-Margret Ervin; Andrew Law; Andrew D Pucker
Journal:  Cochrane Database Syst Rev       Date:  2017-06-26

Review 2.  Tear film lipids.

Authors:  Igor A Butovich
Journal:  Exp Eye Res       Date:  2013-06-12       Impact factor: 3.467

3.  Severe symptoms of short tear break-up time dry eye are associated with accommodative microfluctuations.

Authors:  Minako Kaido; Motoko Kawashima; Reiko Ishida; Kazuo Tsubota
Journal:  Clin Ophthalmol       Date:  2017-05-05

Review 4.  Defining Dry Eye from a Clinical Perspective.

Authors:  Kazuo Tsubota; Stephen C Pflugfelder; Zuguo Liu; Christophe Baudouin; Hyo Myung Kim; Elisabeth M Messmer; Friedrich Kruse; Lingyi Liang; Jimena Tatiana Carreno-Galeano; Maurizio Rolando; Norihiko Yokoi; Shigeru Kinoshita; Reza Dana
Journal:  Int J Mol Sci       Date:  2020-12-04       Impact factor: 5.923

5.  A Practical Approach to Severity Classification and Treatment of Dry Eye Disease: A Proposal from the Mexican Dry Eye Disease Expert Panel.

Authors:  Alejandro Rodriguez-Garcia; Alejandro Babayan-Sosa; Arturo Ramirez-Miranda; Concepcion Santa Cruz-Valdes; Everardo Hernandez-Quintela; Julio C Hernandez-Camarena; Nallely Ramos-Betancourt; Regina Velasco-Ramos; Raul E Ruiz-Lozano
Journal:  Clin Ophthalmol       Date:  2022-04-28

6.  Bioengineered Lacrimal Gland Organ Regeneration in Vivo.

Authors:  Masatoshi Hirayama; Kazuo Tsubota; Takashi Tsuji
Journal:  J Funct Biomater       Date:  2015-07-30

7.  The Association between Dry Eye Disease and Physical Activity as well as Sedentary Behavior: Results from the Osaka Study.

Authors:  Motoko Kawashima; Miki Uchino; Norihiko Yokoi; Yuichi Uchino; Murat Dogru; Aoi Komuro; Yukiko Sonomura; Hiroaki Kato; Yuji Nishiwaki; Shigeru Kinoshita; Kazuo Tsubota
Journal:  J Ophthalmol       Date:  2014-11-17       Impact factor: 1.909

8.  Relation of accommodative microfluctuation with dry eye symptoms in short tear break-up time dry eye.

Authors:  Minako Kaido; Motoko Kawashima; Yuta Shigeno; Yoshiaki Yamada; Kazuo Tsubota
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

9.  Changes in Distribution of Dry Eye Disease by the New 2016 Diagnostic Criteria from the Asia Dry Eye Society.

Authors:  Takenori Inomata; Tina Shiang; Masao Iwagami; Fumika Sakemi; Keiichi Fujimoto; Yuichi Okumura; Mizu Ohno; Akira Murakami
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.